July 18, 2008

From the News Wire: Lantus vs NPH: Safer not better control

Long-Acting Insulins in Type 1 Diabetes Safer Than Traditional Agents

For type 1 diabetes, long-acting insulins such as glargine (Lantus) reduce severe hypoglycemic episodes but don't offer clinically significant improved glycemic control, according to a meta-analysis.